Thermo Fisher Scientific Inc (TMO)
595.30
-1.85
(-0.31%)
USD |
NYSE |
May 17, 16:00
595.32
+0.02
(+0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Cash from Operations (Quarterly): 1.251B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.251B |
December 31, 2023 | 3.723B |
September 30, 2023 | 2.414B |
June 30, 2023 | 1.54B |
March 31, 2023 | 729.00M |
December 31, 2022 | 3.487B |
September 30, 2022 | 1.937B |
June 30, 2022 | 1.528B |
March 31, 2022 | 2.202B |
December 31, 2021 | 2.457B |
September 30, 2021 | 2.65B |
June 30, 2021 | 2.227B |
March 31, 2021 | 1.978B |
December 31, 2020 | 3.339B |
September 30, 2020 | 2.708B |
June 30, 2020 | 1.886B |
March 31, 2020 | 356.00M |
December 31, 2019 | 1.913B |
September 30, 2019 | 1.117B |
June 30, 2019 | 1.294B |
March 31, 2019 | 649.00M |
December 31, 2018 | 1.801B |
September 30, 2018 | 1.22B |
June 30, 2018 | 1.444B |
March 31, 2018 | 78.00M |
Date | Value |
---|---|
December 31, 2017 | 1.866B |
September 30, 2017 | 929.00M |
June 30, 2017 | 849.00M |
March 31, 2017 | 361.00M |
December 31, 2016 | 1.205B |
September 30, 2016 | 804.40M |
June 30, 2016 | 913.60M |
March 31, 2016 | 334.70M |
December 31, 2015 | 1.353B |
September 30, 2015 | 743.90M |
June 30, 2015 | 764.90M |
March 31, 2015 | 80.00M |
December 31, 2014 | 953.70M |
September 30, 2014 | 676.00M |
June 30, 2014 | 888.70M |
March 31, 2014 | 101.20M |
December 31, 2013 | 728.50M |
September 30, 2013 | 505.50M |
June 30, 2013 | 478.40M |
March 31, 2013 | 298.30M |
December 31, 2012 | 660.10M |
September 30, 2012 | 479.90M |
June 30, 2012 | 507.50M |
March 31, 2012 | 392.00M |
December 31, 2011 | 637.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
356.00M
Minimum
Mar 2020
3.723B
Maximum
Dec 2023
2.037B
Average
1.958B
Median
Cash from Operations (Quarterly) Benchmarks
Fonar Corp | 2.807M |
XWELL Inc | -3.201M |
ProPhase Labs Inc | -5.119M |
Applied DNA Sciences Inc | -3.21M |
Veracyte Inc | -8.966M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -2.03B |
Cash from Financing (Quarterly) | -1.821B |
Free Cash Flow | 7.56B |
Free Cash Flow Per Share (Quarterly) | 2.354 |
Free Cash Flow to Equity (Quarterly) | 213.00M |
Free Cash Flow to Firm (Quarterly) | 973.15M |
Free Cash Flow Yield | 3.28% |